DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Rao S et al.
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
Am J Gastroenterol 2012;
107 (11) 1714-1724 quiz 1725
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.